INEGY 10 MG80 MG TABLETS

Land: Israel

Språk: engelska

Källa: Ministry of Health

Aktiva substanser:

EZETIMIBE; SIMVASTATIN

Tillgänglig från:

MERCK SHARP & DOHME ISRAEL LTD

ATC-kod:

C10AA01

Läkemedelsform:

TABLETS

Sammansättning:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Administreringssätt:

PER OS

Receptbelagda typ:

Required

Tillverkad av:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Terapeutisk grupp:

SIMVASTATIN

Terapiområde:

SIMVASTATIN

Terapeutiska indikationer:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Tillstånd datum:

2012-04-30